Hormone replacement therapy and colorectal cancer

Alicja Bednarowska-Flisiak; Małgorzata Bińkowska

Abstract

2/2003 vol. 2

Hormone replacement therapy and colorectal cancer

Alicja Bednarowska-Flisiak

,

Małgorzata Bińkowska

(Prz Menopauz 2003, 2: 68–72)

Online publish date: 2003/04/11

View full text

AMA

Bednarowska-Flisiak A, Bińkowska M. Hormone replacement therapy and colorectal cancer. Menopause Review/Przegląd Menopauzalny. 2003;2(2):68-72.

APA

Bednarowska-Flisiak, A., & Bińkowska, M. (2003). Hormone replacement therapy and colorectal cancer. Menopause Review/Przegląd Menopauzalny, 2(2), 68-72.

Chicago

Bednarowska-Flisiak, Alicja, and Małgorzata Bińkowska. 2003. "Hormone replacement therapy and colorectal cancer". Menopause Review/Przegląd Menopauzalny 2 (2): 68-72.

Harvard

Bednarowska-Flisiak, A., and Bińkowska, M. (2003). Hormone replacement therapy and colorectal cancer. Menopause Review/Przegląd Menopauzalny, 2(2), pp.68-72.

MLA

Bednarowska-Flisiak, Alicja et al. "Hormone replacement therapy and colorectal cancer." Menopause Review/Przegląd Menopauzalny, vol. 2, no. 2, 2003, pp. 68-72.

Vancouver

Bednarowska-Flisiak A, Bińkowska M. Hormone replacement therapy and colorectal cancer. Menopause Review/Przegląd Menopauzalny. 2003;2(2):68-72.

Colorectal cancer is one of the leading causes of cancer deaths. The protective role of endogenous and exogenous estrogens in colon carcinogenesis is still under study. The analysis and meta-analysis of hormone replacement therapy (HRT) studies suggest a noticeable reduction in colon cancer among current and recent users. The 2002 results of randomized controlled study – Women’s Health Initiative confirm a 36% reduction of colorectal cancer in HRT users.

Keywords

hormone replacement therapy, colorectal cancer

Share

Coverage in

Indexed in

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications